(1)
Cost-Effectiveness Analysis of Budesonide Formoterol and Fluticasone Salmeterol for Stable Chronic Obstructive Lung Disease. J Respirol Indones 2022, 42 (4), 289–297. https://doi.org/10.36497/jri.v42i4.378.